Cargando…
The Efficacy, Safety, and Outcomes of Brain‐responsive Neurostimulation (RNS® System) therapy in older adults
OBJECTIVES: The gold standard for the management of drug‐resistant focal epilepsy (DRE) is resection of epileptogenic zone. However, some patients may not be candidates for resection. Responsive neurostimulation is approved in patients above 18 years of age for such patients. We aimed to investigate...
Autores principales: | Zawar, Ifrah, Krishnan, Balu, Mackow, Michael, Alexopoulos, Andreas, Nair, Dileep, Punia, Vineet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633477/ https://www.ncbi.nlm.nih.gov/pubmed/34543516 http://dx.doi.org/10.1002/epi4.12541 |
Ejemplares similares
-
Trigeminal paresthesia secondary to responsive neurostimulation (RNS) lead migration
por: Haneef, Zulfi, et al.
Publicado: (2021) -
Treatment of Multi-Focal Epilepsy With Resective Surgery Plus Responsive Neurostimulation (RNS): One Institution's Experience
por: Tran, Diem Kieu, et al.
Publicado: (2020) -
Nine-year prospective efficacy and safety of brain-responsive neurostimulation for focal epilepsy
por: Nair, Dileep R., et al.
Publicado: (2020) -
Two-year seizure reduction in adults with medically intractable partial onset epilepsy treated with responsive neurostimulation: Final results of the RNS System Pivotal trial
por: Heck, Christianne N, et al.
Publicado: (2014) -
Determinants and outcome of repeat continuous electroencephalogram monitoring—A case‐control study
por: Punia, Vineet, et al.
Publicado: (2019)